The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
about
Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Binding to and Inhibition of Insulin-Regulated Aminopeptidase by Macrocyclic Disulfides Enhances Spine Density.Small-molecule AT2 receptor agonists.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease.Association between dementia and vascular disease-associated polymorphisms in a Tunisian population.Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.Within the Brain: The Renin Angiotensin System.Patent Highlights October-November 2016.Angiotensin IV suppresses inflammation in the brains of rats with chronic cerebral hypoperfusion
P2860
Q33627982-F366DF09-7F40-4C50-B1A3-FE8C3485BCAEQ35894732-DCA417F6-D015-47B2-82D5-D163B15C1983Q36400573-522BBCB4-B599-46A5-B6B8-DEB142006041Q36925905-11CF4BA0-32E9-4C01-81B4-FF3CA3A232BAQ38781022-F0D80FA4-A44C-4D87-B946-C6A22B4DF1FDQ46316918-482B2D27-00EF-4C64-9636-CACC70B25F55Q48209059-F6002708-4EAE-4454-AE17-D693A9C5D572Q48873920-4BD0CDB8-5A28-4629-93A1-87ADD38AA53EQ49721288-AAFA191E-1758-4537-83CB-3EE896E95BE4Q51242782-C4FFB571-7373-4D4B-8AAE-4BC7D3F8ABA0Q51762826-C3EA7A64-965B-4597-AEED-DD4343ADC4EEQ54380711-C893E951-3A72-4805-8CF3-0AAFAB9B9BF5Q58732246-2BDFDA78-D501-4511-B21A-D07CDD42F0FA
P2860
The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The development of small molec ...... mer's and Parkinson's diseases
@ast
The development of small molec ...... mer's and Parkinson's diseases
@en
The development of small molec ...... mer's and Parkinson's diseases
@nl
type
label
The development of small molec ...... mer's and Parkinson's diseases
@ast
The development of small molec ...... mer's and Parkinson's diseases
@en
The development of small molec ...... mer's and Parkinson's diseases
@nl
prefLabel
The development of small molec ...... mer's and Parkinson's diseases
@ast
The development of small molec ...... mer's and Parkinson's diseases
@en
The development of small molec ...... mer's and Parkinson's diseases
@nl
P2093
P1476
The development of small molec ...... mer's and Parkinson's diseases
@en
P2093
John W Wright
Joseph W Harding
Leen H Kawas
P356
10.1016/J.PNEUROBIO.2014.11.004
P4011
5984504494c095c92a4ca3224de111955582999f
P407
P577
2015-02-01T00:00:00Z